The Biden Cancer Initiative has announced that multiple healthcare organizations — including BreastCancerTrials.org, IBM Watson Health, Massive Bio and Syapse — are creating a shared platform called the Oncology Clinical Trial Information Commons, which will help cancer patients to know their clinical trial options.
"Unfortunately, the announcement lacked many specific actions to effectively implement the initiative," Biden wrote in a Forbes commentary. "I agree with the administration's stated goals, but real action is needed — and now is the time."
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Greg Simon, Biden Cancer Initiative President touched on several topics from changing the culture of science, to highlighting some of the collaborations that emerged from the Cancer Moonshot in a fireside chat at MedCity's CONVERGE conference.
In its first year at SXSW, a series of conversations around the topic of cancer, Connect to End Cancer, spurred some interesting discussion around telemedicine, advice for startups and the role of 5g technology to improve patient-physician encounters.